Rotate your device

Please rotate your device to landscape mode
for the best experience.

AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mencevax Acwy Vaccine

Prescription Icon
Prescription Required

Marketer

Glaxo SmithKline Pharmaceuticals Ltd

Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135) (NA)

Overview Mencevax Acwy Vaccine

The Acwy meningococcal vaccine, Mencevax, offers protection against meningococcal disease. Specifically, it actively immunizes against invasive infections caused by *Neisseria meningitidis* serogroups A, C, Y, and W-135. Recommended for infants (two months and older), adolescents, and adults, its administration follows official guidelines. Always administered by a healthcare provider, self-injection is strictly prohibited. A complete vaccination course is crucial for optimal effectiveness. Minor reactions at the injection site (pain, swelling, redness), along with nausea, headache, drowsiness, irritability, fatigue, and muscle aches, are possible side effects. Report any persistent or worsening symptoms to your physician, who can offer management strategies. Prior to vaccination, disclose any pre-existing medical conditions or medications to your doctor to ensure safety. Pregnant or breastfeeding individuals must consult their doctor before vaccination.

Primary Ingredients of Mencevax Acwy Vaccine

No text provided. Please provide the text you wish me to rephrase.

Uses of Mencevax Acwy Vaccine

Averting Meningococcal Infection

Major Benefits of Mencevax Acwy Vaccine:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of Mencevax Acwy Vaccine:

  • Injection site reaction
  • Sleepiness
  • Nausea
  • Headache
  • Irritation
  • Muscle pain

How to use Mencevax Acwy Vaccine:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Mencevax Acwy Vaccine works:

The Mencevax ACWY vaccine triggers the body's immune response by inducing a harmless, non-disease-causing infection. This process prompts the production of protective antibodies, proteins that defend against subsequent MenACWY infections.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Mencevax Acwy vaccination lacks established safety data. Seek medical advice before combining them.

PregnancyPregnancySAFE IF PRESCRIBED

The Acwy meningococcal vaccine (Mencevax) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; however, clinical data from human trials remain scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The use of Mencevax Acwy Vaccine while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingSAFE

The Mencevax Acwy vaccination typically has no impact on driving capabilities.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding the administration of Mencevax Acwy Vaccine to individuals with renal impairment is scarce. Seek medical advice from your physician.

LiverLiverSAFE IF PRESCRIBED

The use of Mencevax Acwy Vaccine in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates that dose modification may not be necessary for this population. Physician consultation is recommended.

What if you forget to take Mencevax Acwy Vaccine :

Should you forget a scheduled Mencevax ACWY vaccination, seek advice from your physician.

Facts to Know About Mencevax Acwy Vaccine

LabelValue
Chemical Type Immunizations
Developing Habits No.
Treatment Category Immunizations

FAQs on Mencevax Acwy Vaccine

Mencevax ACWY vaccine protects against invasive meningococcal disease caused by serogroups A, C, Y, and W-135. It's approved for individuals aged 2 months to 55 years.
Do not administer Mencevax ACWY vaccine to individuals with a history of allergic reactions to its components or similar medications. Allergic reactions may manifest as rash, shortness of breath, or facial/tongue swelling. Report any prior allergic reactions to your doctor before vaccination.
Individuals aged 15-55 at continued risk of meningococcal disease may receive a single Mencevax ACWY booster dose at least four years after their previous dose. Consult your doctor if you have questions.
Administering the Mencevax ACWY vaccine requires a trained healthcare professional; self-injection is strictly prohibited. It's typically injected into the upper arm muscle, though thigh muscle injection may be used in children. Always adhere to your doctor's instructions for optimal results.
No, the Menveo (or other MenACWY) vaccine cannot cause meningococcal disease. Instead, it stimulates your immune system to produce protective antibodies, enabling your body to fight off infection should you encounter it later.
Mencevax Acwy Vaccine
1,134